- Home
- BNTX
BNTX
BioNTech SE
as 11-15-2024 4:00pm EST
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
| Founded: | 2008 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 26.6B | IPO Year: | 2019 |
| Target Price: | $137.54 | AVG Volume (30 days): | 968.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $76.53 - $131.49 | Next Earning Date: | 11-04-2024 |
| Revenue: | $3,390,698,192 | Revenue Growth: | -54.07% |
| Revenue Growth (this year): | -29.85% | Revenue Growth (next year): | -1.12% |
Latest BioNTech SE News
BNTX Breaking Stock News: Dive into BNTX Ticker-Specific Updates for Smart Investing
Investor's Business Daily
2 days ago
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
Zacks
2 days ago
Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
The Wall Street Journal
2 days ago
Trump’s RFK Jr. Pick Weighs on Vaccine Makers
Yahoo Finance Video
2 days ago
Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
Investor's Business Daily
2 days ago
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
TipRanks
2 days ago
BioNTech SE’s Strategic Growth in Oncology and mRNA
Zacks
3 days ago
BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up
Pharmaceutical Technology
3 days ago
BioNTech signs agreement to acquire Biotheus
Compare BNTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BNTX BioNTech SE - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.